News

The company has closed a $40 million round of private equity financing, with participation from several leading venture capital firms, to support its expanding research and product development

Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed, or Tdap) is indicated to be given as a single dose to individuals aged ten to 18

Data presented at the Association of Research in Vision and Ophthalmology (ARVO) show that Xalacom (latanoprost-timolol maleate ophthalmic solution) demonstrated similar reduction of intraocular pressure (IOP) in patients

Primary immunodeficiency is a group of genetic disorders in which the immune system fails to produce adequate amounts of antibodies, thereby predisposing individuals to increased risk of infection.

Under the agreements, Kos has acquired the anti-hypertensive products Teveten (eprosartan mesylate) and Teveten HCT (eprosartan mesylate/hydrochlorothiazide) from Biovail and has obtained exclusive sales and marketing rights to

Trelstar (triptorelin pamoate for injectable suspension) 3.75mg, one-month slow release, is an injectable, luteinizing hormone-releasing hormone (LHRH) agonist indicated for the palliative treatment of advanced prostate cancer and

The Pirkka yogurts are the first in a series of scheduled product launches planned for later this year incorporating Forbes’ cholesterol-lowering ingredient into a variety of foods. “Kesko

Under the one-year extension, Metabolex will receive research funding and screening and development milestones from Astellas Pharma (formerly Yamanouchi Pharmaceutical). The two companies initiated their research collaboration, focused

The new dosing regimen for Kaletra (lopinavir/ritonavir) is available in both liquid and soft gel capsule formulations and offers physicians and patients increased flexibility in managing their HIV